Cart
sales@molnova.com
Orilotimod potassium
CAS No. 960155-19-5
Orilotimod potassium( —— )
Catalog No. M36132 CAS No. 960155-19-5
Orilotimod potassium (APO805K1) can be used to study plaque psoriasis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 120 | In Stock |
|
| 10MG | 177 | In Stock |
|
| 25MG | 334 | In Stock |
|
| 50MG | 440 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameOrilotimod potassium
-
NoteResearch use only, not for human use.
-
Brief DescriptionOrilotimod potassium (APO805K1) can be used to study plaque psoriasis.
-
DescriptionOrilotimod potassium (APO805K1) can be used to study plaque psoriasis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number960155-19-5
-
Formula Weight371.43
-
Molecular FormulaC16H18KN3O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOC([C@H](N)CCC(N[C@@H](C([O-])=O)CC1=CNC2=CC=CC=C12)=O)=O.[K+]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
URAT1 inhibitor 7
URAT1 inhibitor 7 is a novel and potent inhibitor of the human uric acid transporter protein URAT1 (IC50:12 nM).URAT1 inhibitor 7 inhibits CYP2C9 with an IC50 of 4.2 μM.URAT1 inhibitor 7 can be used to study hyperuricemia and gout.
-
Lucidenic acid O
Lucidenic acid O is a terpene compound, is a DNA polymerases inhibitor. Lucidenic lactone inhibits calf DNA polymerase-α, rat DNA polymerase-β, and HIV-1 reverse transcriptase with IC50 values of 42 μM, 99 μM, and 69 μM, respectively.
-
Kinase Domain of Ins...
Kinase Domain of Insulin Receptor (5)
